Financial Data and Key Metrics Changes - The company reported net income of $48 million, a significant increase from $18.9 million in the same quarter last year, reflecting a positive trajectory in earnings [4][12] - Gross premiums earned rose to $353.6 million, up 1% from $350.1 million in the prior year quarter, indicating higher gross premiums written due to business growth and rating actions [12] - Net premiums earned increased to $196.3 million, up 3.2% from $190.3 million in the prior year quarter, driven by higher gross premiums earned and a reduction in ceded premiums [13] - The net loss ratio improved by 17.2 points to 38.5% compared to 55.7% in the same quarter last year, reflecting significantly lower net losses [14] - The net combined ratio for the quarter was 72.9%, an improvement of 19.6 points from 92.5% in the prior year quarter, driven by a lower net loss ratio and lower net expense ratio [16] Business Line Data and Key Metrics Changes - The company reunderwrote its personal lines book and implemented necessary rate increases, leading to a steady contraction of over 200,000 policies in force over the last four years [5] - In the second quarter, policies in force decreased by just over 7,700, the smallest decrease since the initiative began in June 2021, indicating a potential inflection point for growth [5] - New business production increased by 46% compared to 2024, reaching the highest level since 2022, with expectations for growth to accelerate in 2026 [6] Market Data and Key Metrics Changes - The company noted strong new business momentum in the Northeast, particularly in New York, and the Mid Atlantic, with Virginia showing strong new business trends [6] - Florida is highlighted as a standalone market with recent legislative reforms positively impacting the economics of writing new, profitable business [7] Company Strategy and Development Direction - The company is focused on a managed growth strategy, aiming to return policies in force to moderate growth in the latter half of the year before accelerating in 2026 [11] - Continued investment in customer service, claims management, and technology resources is emphasized, with an ongoing IT conversion to a Guidewire platform expected to enhance operational efficiency [9] - The company maintains a disciplined underwriting process while opening new territories, which has resulted in a lower net loss ratio this quarter [8] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the growth opportunities across various regions, citing significant room for expansion and market share growth [7] - The company anticipates a favorable impact on reinsurance pricing in 2026 due to legislative changes in Florida and the maturation of Hurricane Milton's claims [10] - Management reiterated a commitment to long-term profitability, shareholder value, and customer service, driven by a dedicated workforce [11][19] Other Important Information - The company ended the quarter with total assets of $2.5 billion and shareholders' equity of $383.3 million, with book value per share increasing to $12.36, up 30.1% from the previous year [17] - The refinancing of senior credit facilities was completed on favorable terms, increasing the facility to $200 million while extending the maturity to July 2030 [18] Q&A Session Summary Question: Can you discuss the attritional loss trajectory over the last year and through the second quarter? - Management indicated that attritional losses are stabilizing, with frequency continuing to decline and severity running at a modest rate, suggesting a potential leveling off [24][25] Question: How do you see the competition in the market, especially with recent public equity offerings in Florida? - Management noted that agents are enthusiastic about the company's reopening and welcomed responsible competition, although new carriers are primarily focusing on the citizens take-out program [27][28] Question: What are the expected trends for primary rates for the remainder of the year? - Management expects primary rates to trend upward across most geographies, but at a moderated pace due to achieving rate adequacy [30] Question: How has the loss experience been in the Northeast and Mid Atlantic markets? - Management stated that the Northeast is expected to see positive growth, with recent rate approvals aiding the process [32] Question: Can you compare catastrophe and weather losses to prior years? - Management reported a year-over-year decrease in non-catastrophe weather losses, attributing it to improved underwriting performance and better risk management [36] Question: Can you elaborate on prior period development and reserve strengthening? - Management confirmed that some favorable development is due to reserve strengthening from the previous year, indicating a positive trend [38]

Financial Data and Key Metrics Changes - The company achieved second quarter sales of over $2.75 billion, reflecting a 3% year-over-year increase, with adjusted operating EBITDA of $552 million, a solid 6% increase [12][17] - The net debt to EBITDA ratio improved to 2.5 times, marking the first time below 3.0 times since 2018 [6][8] - Free cash flow for Q2 totaled $94 million, a sequential increase of over $140 million from the previous quarter [17] Business Line Data and Key Metrics Changes - Pharma Solutions reported sales of $103 million, a 21% year-over-year increase, but this segment will no longer be reported following its divestiture [13] - Taste segment sales reached $631 million, a 6% increase, with profitability growth driven by volume and favorable net pricing [14] - Health and Biosciences grew 4% in the quarter, with adjusted operating EBITDA of $151 million, a 3% increase [15] - Scents achieved sales growth of 1% year-over-year, with adjusted operating EBITDA impacted by unfavorable net pricing [16] Market Data and Key Metrics Changes - Growth in the Taste segment was strongest in Latin America and the Europe, Africa, and Middle East region [14] - The company noted challenges in North America and China, particularly in the Health and Biosciences segment, which is expected to see negative growth in Q3 [40][56] Company Strategy and Development Direction - The company is focusing on divesting non-core businesses to enhance margins and streamline operations, with a goal of achieving mid-teens EBITDA margins in the food ingredients business [8][9] - A new $500 million share repurchase authorization was announced, reflecting confidence in the company's future and a balanced capital allocation strategy [9][19] - The company is committed to increasing free cash flow generation and prioritizing investments in high-return areas [18][21] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in navigating a challenging operating environment and reiterated full-year 2025 guidance, expecting sales growth at the lower end of 1% to 4% [10][22] - The company anticipates a moderation in growth, particularly in Q3, due to strong prior year comparisons [23][40] - Management highlighted the importance of innovation and R&D investments to drive future growth, particularly in 2026 and beyond [11][56] Other Important Information - The company completed the divestiture of its Pharma Solutions and Nitrocellulose businesses, which has strengthened its financial position [6][8] - The divestiture of soy crush concentrates and lecithin business to Bunge was also announced, allowing the company to focus on differentiated innovation [8][27] Q&A Session Summary Question: Strategic rationale behind the divestiture to Bunge - The divested soy products were commoditized with low single-digit EBITDA margins, allowing the company to focus on higher-margin isolated soy protein business [27][28] Question: Timeline for evaluating strategic alternatives for Food Ingredients - The company expects to provide updates on strategic options by the fourth quarter earnings call early next year, with strong interest from private equity and strategic buyers [30][34] Question: Monthly cadence of Q2 performance and volume assumptions for the second half - All businesses delivered growth in Q2, but management is cautious about the second half due to strong year-over-year comparisons [36][40] Question: Outlook for the Scent segment in Q3 and Q4 - Fine Fragrance is expected to continue strong performance, while Fragrance Ingredients will face pressure from commodity elements [42][46] Question: Changes in board composition and its impact - The company has strengthened its leadership and board to drive innovation and market leadership in scent, taste, and health [50][52] Question: Performance of Health and Biosciences segment - Food biosciences and home care are performing well, but health is expected to see a slowdown in the second half [55][56] Question: Market response to potential regulatory changes - Customers are seeking cleaner labels and reformulation opportunities, which aligns with the company's capabilities [65][66] Question: Differences in performance between global and local customers - Global companies are focusing on innovation, while local players are emerging with strong growth in developing markets [94][95]

Financial Data and Key Metrics Changes - The company reported Q2 revenues of $77 million, a 6% increase over 2024, and year-to-date revenues of $155 million, reflecting a 12% increase over 2024 [6][18] - The balance sheet remains strong with $201 million in cash and access to $500 million in non-dilutive capital from Blackstone [7][22] - Total revenues over the trailing four quarters exceeded $300 million, with expectations for continued growth [18] Business Line Data and Key Metrics Changes - The endocrine business unit generated $18.3 million in revenue, representing a 13% growth over 2024 [6] - Afrezza net revenues for Q2 were $18 million, a 13% increase year-over-year, while V Go net revenue was approximately $4 million, an 8% decrease [19][20] - Tyvaso DPI royalties contributed $31 million in Q2, marking a 22% increase from the same quarter last year [18] Market Data and Key Metrics Changes - The company targets about 25% of all rapid-acting scripts, with 1% of the rapid-acting market estimated at a $300 million run rate for Afrezza [4] - The NTM market is expected to exceed $1 billion by the end of the decade, with a focus on the US and Japan [7] Company Strategy and Development Direction - The company is focused on creating shareholder value, minimizing dilution, and enhancing flexibility for future growth [3] - Upcoming trials include the launch of the inflow trial for NTM by the end of 2025 and the pediatric indications for Afrezza [6][14] - The company aims to enhance its commercial infrastructure and expand its sales force in preparation for the pediatric launch of Afrezza [16][73] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the upcoming TETON-two results and their potential impact on business plans [3][14] - The company anticipates continued growth in royalty revenue driven by Tyvaso DPI sales and expects Afrezza to maintain its growth trajectory [20][21] - Management highlighted the importance of the Blackstone deal in providing the necessary capital for growth and innovation [25][22] Other Important Information - The company has entered into a strategic financing arrangement with Blackstone, providing access to up to $500 million in non-dilutive funding [22] - The company is preparing for a new marketing campaign called "insulin in the moment" to enhance awareness and adoption of Afrezza [15] Q&A Session Summary Question: Can you walk us through the timeline for a potential bridging study in IPF? - Management indicated that the timeline could be faster than previous studies, depending on the results of TETON-two and TETON-one [30][31] Question: How is the intended DPI program positioned in the current treatment landscape? - Management noted that the program is designed to be used in combination with existing therapies and is focused on patients intolerant to current treatments [34][40] Question: What is the typical Afrezza patient profile today? - The breakdown of patients is approximately 45% Type 1 and 55% Type 2, with a growing focus on Type 1 patients [66][67] Question: What are the conditions for drawing additional capital from the Blackstone agreement? - The company can draw funds at its discretion without specific sales or development milestones [98]

Financial Data and Key Metrics Changes - Revenue for Q2 2025 was $70.2 million, down 3% from $72.6 million in Q2 2024 [5][10] - Adjusted earnings per share was $0.56, similar to Q2 2024 results [5] - Net income from continuing operations was $2 million or $0.33 per diluted share, compared to $4.1 million or $0.65 per diluted share in Q2 2024 [12] - Gross margin as a percentage of net sales decreased to 23.3% from 25.4% in the prior year [10][11] - Senior net leverage ratio increased to 1.32 from 1.23 in the previous year [13] Business Line Data and Key Metrics Changes - Eberhard is ramping up participation in the new USPS delivery vehicle program, indicating a strategic focus on custom-engineered solutions [6] - The backlog as of June 28, 2025, decreased by $20 million or 19% to $87.1 million, driven by decreased orders for returnable transport packaging and latch and handle assemblies [10] Market Data and Key Metrics Changes - The heavy truck and automotive markets are currently challenging, with reduced model changes expected to increase in the future [15] - The Class eight truck fleet age has increased significantly, which may lead to increased demand as maintenance costs rise [15][16] Company Strategy and Development Direction - The company is focused on margin protection and has built flexible and resilient supply chains [17] - There is an intention to be active but disciplined in M&A opportunities due to the challenging environment [17] - A share buyback program was completed with 400,000 shares purchased, including 82,000 shares in the quarter [7][13] Management's Comments on Operating Environment and Future Outlook - Management acknowledges the impact of the business environment on top-line performance but expects recovery in the coming months [16] - The leadership team is in place with a strategic refresh across businesses, positioning the company for future success [20] Other Important Information - The company undertook salaried headcount reductions impacting over 60 jobs, resulting in annual savings of $4 million [6] - Capital expenditures for the quarter were $800,000, and dividends paid were $700,000 [13] Q&A Session Summary - There were no questions from participants during the Q&A session [19]

Financial Data and Key Metrics Changes - In Q2 2025, the company generated $46 million of free cash flow and $203 million over the last twelve months, despite key commodities trading at or near operators' cost of production [6][7] - The net income for Q2 2025 was $34 million, with the mineral rights segment contributing $40 million in net income, a decrease of $13 million compared to the prior year [13] Business Line Data and Key Metrics Changes - The mineral rights segment's operating and free cash flow each decreased by $11 million year-over-year due to weaker coal markets [13] - The soda ash segment generated $3 million in net income, down $1 million from the previous year, with operating and free cash flow each decreasing by $3 million due to lower sales prices [14] Market Data and Key Metrics Changes - The metallurgical coal market remains under pressure with soft demand for steel and high coal inventories, leading to operators selling coal at or near production costs [7][8] - The soda ash market is significantly oversupplied, with prices below production costs for most producers, and expected to remain low until demand rebounds or supply rationalizes [10][11] Company Strategy and Development Direction - The company aims to pay off substantially all debt by mid-next year and increase unitholder distributions starting next August [7][12] - Future cash priorities post-deleveraging will focus on unitholder distributions, unit repurchases, and opportunistic investments [21] Management's Comments on Operating Environment and Future Outlook - Management noted that many operators are in better financial shape than in previous downturns, which bodes well for the industry [8][9] - The current market for key commodities is as negative as ever, but the company continues to generate robust free cash flow [11] Other Important Information - The company has not made significant progress on COVID carbon neutral initiatives, with the market for most C and I activities remaining stagnant [11] Q&A Session Summary Question: Are there opportunities to acquire additional royalty or soda ash assets post-debt repayment? - Management indicated that while the mineral rights market is fragmented and not very active, there are always possibilities for one-off transactions [19][20] Question: What are the priorities for cash after achieving a debt-free status? - Management stated that priorities will be unitholder distributions, unit repurchases at discounts, and opportunistic investments in assets at bargain prices [21] Question: Is there potential for other mineral opportunities across the company's land? - Management acknowledged the possibility of future opportunities but did not specify any current targets [22]

Financial Data and Key Metrics Changes - The company generated total revenue of $1.6 billion for the quarter, an 8% decrease compared to the second quarter of last year, primarily driven by 60 fewer stores in operation and reduced consumer traffic [23][24] - Adjusted EBITDA was $47 million in the quarter, compared to $57 million in the prior year, reflecting a decline due to restructuring expenses [25] - Adjusted free cash flow for the quarter was $13 million, a significant increase from $5 million in the same period last year, highlighting improved cash generation [27][36] Business Line Data and Key Metrics Changes - In the B2B distribution segment, revenue trends improved by approximately 200 basis points year over year, driven by new business wins and stronger demand [10][30] - The retail segment, Office Depot, reported sales of $716 million, down 10% year over year, but comparable store sales improved by 200 basis points [28][29] - The supply chain business, Veyr, achieved a 90% year-over-year revenue growth from third-party customers, with third-party revenue reaching $19 million [34][35] Market Data and Key Metrics Changes - The company is making significant progress in the hospitality market, with a strategic partnership covering approximately 15,000 members, positioning ODP to enter a $16 billion segment [15][16] - Sales to hospitality customers rose by a low double-digit percentage, indicating early traction in this new market [32] Company Strategy and Development Direction - The company's strategy focuses on leveraging supply chain strengths to accelerate growth in the B2B business while maximizing value from the retail segment [6][7] - The "Optimize for Growth" plan aims to streamline fixed costs and improve margins while expanding into higher growth sectors like hospitality and healthcare [20] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in maintaining momentum into the second half of the year, expecting additional top-line improvement in B2B distribution and sustained strength in retail [22][42] - The company anticipates generating over $115 million in adjusted free cash flow for the full year, supported by strong cash generation and disciplined working capital management [39][41] Other Important Information - The company closed 23 retail stores and three distribution facilities as part of its restructuring efforts [24][20] - Total liquidity at quarter-end was $658 million, consisting of $177 million in cash and $481 million in available credit [38] Q&A Session Summary Question: Are there alternatives being explored to maximize shareholder value? - Management emphasized that maximizing shareholder value is the primary focus, but they cannot comment on specific activities or rumors [46][47] Question: What assumptions have been made regarding the macroeconomic environment, particularly the labor market? - Management stated they are conservative in their assumptions and have a strong focus on inventory management to ensure cash flow generation [48][50] Question: What percentage of the assortment is subject to tariffs, and how will pricing be adjusted? - Approximately 57% of inventory is either MAP priced or exempt from tariffs, allowing flexibility in pricing strategies [53][58] Question: What needs to happen for the business solutions segment to return to positive revenue trends? - Continued execution and focus on hospitality growth are essential, with a strong emphasis on onboarding new properties [86][89]

Financial Data and Key Metrics Changes - Same store RevPAR declined 3.6%, driven by a 3.3% decline in average daily rate [5][9] - Second quarter occupancy was 78%, representing the second highest nominal occupancy in the past five years [6] - Year-to-date operating expenses increased 1.5% on relatively flat occupancy, limiting EBITDA margin contraction to 160 basis points year over year [11][27] - Second quarter adjusted EBITDA was $50.9 million, and adjusted FFO was $32.7 million or $0.27 per share [27][33] Business Line Data and Key Metrics Changes - RevPAR index grew by nearly 150 basis points to 115%, with the NCI portfolio achieving a 114% index, reflecting successful revenue strategies [10] - Food and beverage revenues increased 93% due to re-concepting efforts and new fee implementations [24] - Contract labor costs declined by 13% on both a nominal and per occupied room basis compared to the previous year [26] Market Data and Key Metrics Changes - San Francisco and Chicago saw RevPAR increases of 18% and 10% respectively, driven by resilient group and business transient demand [19] - Orlando's RevPAR increased by 9%, supported by leisure demand following the opening of a new theme park [20] - Government-related demand declined over 20% year over year, impacting overall performance [8] Company Strategy and Development Direction - The company plans to continue share repurchase activities funded by asset sales, with two hotels under contract for sale [12][74] - Emphasis on managing expenses aggressively to mitigate the effects of lost revenue on per share metrics [15][65] - The company is optimistic about future demand stabilization and pricing environment due to limited new hotel supply growth [17][51] Management's Comments on Operating Environment and Future Outlook - Management expects operating trends to improve in the fourth quarter, driven by demand stabilization and a stronger convention calendar [15][63] - Current forecasts for the third quarter reflect a RevPAR decline of approximately 3%, with expectations for improvements in August and September [14][33] - Management remains confident in the long-term outlook for the industry despite near-term macroeconomic uncertainties [33] Other Important Information - The company has reduced its full-year capital expenditure guidance to $60 million to $65 million on a pro-rata basis [33] - The Board of Directors declared a quarterly common dividend of $0.08 per share, representing a dividend yield of over 6% [32] Q&A Session Summary Question: Inquiry about buybacks in the quarter - Management indicated that the timing of buybacks was influenced by cash flow management and market conditions, with a focus on opportunistic usage going forward [38][39] Question: Transition of management and its impact - Management confirmed that the economics remain similar post-transition, primarily aimed at focusing operations [40] Question: Changes in demand segmentation - Management noted pressure in higher-rated segments, with a shift towards advanced purchase business to build demand [45][46] Question: Stability of government demand - Management observed stabilization in government demand after a rapid contraction, expecting it to remain stable at lower levels [79] Question: Lower CapEx guidance - Management explained that the reduction is related to timing and the decision to sell assets needing significant renovations rather than renovating them [80] Question: Future pricing power and demand trends - Management emphasized that overall better demand trends across all segments are necessary for improved pricing power [82][83]

Financial Data and Key Metrics Changes - Consolidated sales for Q3 2025 were $349 million, down from $428 million in Q3 2024, primarily due to the divestiture of SGK [5][28] - Net income increased to $15.4 million or $0.49 per share compared to $1.8 million or $0.06 per share a year ago, reflecting a gain from the SGK divestiture [27] - Consolidated adjusted EBITDA for Q3 2025 was $44.6 million, slightly down from $44.7 million in the previous year, indicating stability despite the divestiture [29] Business Line Data and Key Metrics Changes - Memorialization segment sales increased to $203.7 million from $202.7 million year-over-year, driven by the Dodge acquisition and inflationary pricing [31] - Industrial Technology segment sales decreased to $87.9 million from $91.7 million, primarily due to lower engineering sales, although warehouse automation showed improvement [33] - Brand Solutions segment sales fell to $57.7 million from $133.4 million, significantly impacted by the SGK divestiture [36] Market Data and Key Metrics Changes - The warehouse automation market is experiencing positive order trends, with significant increases in backlog due to renewed interest in automation technologies [14] - U.S. e-commerce is projected to grow by 10% in 2025, indicating a favorable market environment for the company's automation solutions [15] Company Strategy and Development Direction - The company is focused on a value creation plan aimed at simplifying corporate structure, reducing costs, and expanding into higher growth and margin businesses [6][9] - The merger of SGS and SGK is expected to create significant value, with projected annual adjusted EBITDA of about $100 million for Propellus Group [6][7] - The company is maintaining its previous earnings guidance of at least $190 million in adjusted EBITDA for 2025, despite the impact of the SGK divestiture [40] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the early results of cost reduction initiatives and the potential for further debt reduction [9][24] - The company anticipates a return to normal revenue and pricing cadence in the memorialization segment for the remainder of the year [11] - Management noted ongoing legal disputes with Tesla but remains confident in the strength of its proprietary technology and market position [20][22] Other Important Information - The company expects to close the sale of remaining SGK German assets, further simplifying its structure and reducing debt levels [9] - Cash flow used in operating activities for Q3 2025 was $15.2 million, a decline from cash provided by operating activities of $13.5 million in the previous year [37] Q&A Session Summary Question: What was the EBITDA contribution from the Dodge Company this quarter? - The EBITDA contribution was approximately $1 million on $6 million in sales, consistent with previous estimates [43] Question: What was the energy storage related revenue for the quarter? - Sales in the energy business were down from a year ago, primarily due to ongoing issues discussed earlier [44] Question: How much synergy is expected between the new print head business and warehouse automation? - The connection between warehouse automation and the new print head business is significant, with expectations for future synergies as the products are rolled out [50][54] Question: Has the RotoGravir sale closed? - The sale is expected to close before September 30, generating over $30 million in net cash [70] Question: What is the status of the European packaging sale? - The European packaging business has an annual revenue run rate of about $50-60 million, with EBITDA being relatively breakeven [73] Question: Any updates on the legal front with Tesla? - Tesla has filed additional suits seeking to overturn a favorable ruling, but the likelihood of success is low [84]

Financial Data and Key Metrics Changes - For the second quarter of 2025, consolidated revenue increased by 10%, adjusted EBITDA grew by 17%, and adjusted EPS was up by 29% [6][27][25] - The company reported strong profit margin growth, reflecting the resilience of its platform and confidence in the revised full-year outlook [27][25] Business Line Data and Key Metrics Changes - Real Estate Management Services (REMS) revenue growth was led by Workplace Management, with nearly 30% growth on a two-year stacked basis [13] - Project Management revenue growth was broad-based, particularly in the U.S. and Asia Pacific, with mid-teens management fee growth [13] - Capital Markets Services saw a 27% increase in debt advisory revenue and a 9% growth in investment sales, with a two-year stack growth of 25% for both [19] - Software and technology solutions experienced low double-digit growth in software revenue, offset by reduced technology solutions spending from large clients [22] Market Data and Key Metrics Changes - The U.S. industrial market led growth with a 13% increase, while global office leasing revenue tracked in line with market volume, showing a deceleration in growth [16][17] - The leasing advisory segment saw nearly 3% growth in U.S. office leasing revenues, contrasting with a 3% decline in market volume [17] Company Strategy and Development Direction - The company is focused on organic growth, enhancing operational efficiency, and investing in data technology and artificial intelligence to meet client demand for integrated real estate management solutions [9][25] - There is a commitment to returning capital to shareholders through increased share repurchases while considering M&A opportunities that augment organic initiatives [25][59] Management's Comments on Operating Environment and Future Outlook - Management noted an uptick in delayed decision-making in industrial and manufacturing sectors due to geopolitical and trade policy pressures, but expressed optimism about the stability of the pipeline for midsized capital projects [7][27] - The overall market backdrop remains constructive, with expectations for continued organic growth and market share gains [25][27] Other Important Information - The company raised $1 billion in private equity capital in the second quarter, bringing the year-to-date total to $2.9 billion [21] - Liquidity totaled $3.3 billion at the end of the second quarter, with an improvement in reported net leverage to 1.2 times, down from 1.7 times a year earlier [23] Q&A Session Summary Question: Strength of project management deals and revenue growth expectations - Management expressed optimism about the strength of the project management business, expecting continued demand for midsized projects [30] Question: Revenue growth expectations in REMS - Management indicated expectations of high single-digit to low double-digit revenue growth in REMS over the medium term, with recent contract wins contributing positively [31][32] Question: Growth drivers for JLL moving into 2026 - Management highlighted that the Capital Markets business is sensitive to geopolitical noise, but stable interest rates could support transaction volume growth [33] Question: Capital markets pipeline and deal activity - Management reported a strong pipeline across asset classes, particularly in retail and residential, with optimism for continued performance in Capital Markets [38] Question: Fannie Mae loan loss risks - Management confirmed ongoing monitoring of the portfolio for potential fraud, with no specific areas identified at this time [41] Question: Elevated contract churn in property management - Management acknowledged potential elevated contract turnover as part of a strategy to focus on long-term growth and profitability [42] Question: Margin expansion expectations - Management expects margin expansion to be stronger in the latter half of the year, though not necessarily linear [46][48] Question: Geographic split in capital markets business - Management indicated that approximately 60% of capital markets business is in the Americas and 40% in the rest of the world [54] Question: Capital allocation priorities - Management confirmed an increase in share repurchases while maintaining a focus on organic growth investments [59]

Financial Data and Key Metrics Changes - The company reported total revenue of $869.2 million for Q2 2025, representing a 9.2% increase year-over-year [5][19] - Adjusted EBITDA for the quarter was $201.8 million, reflecting a 7.5% increase compared to the same period last year, with an adjusted EBITDA margin of 23.2% [5][19] - Same facility revenue grew by 9.5% year-over-year, including a 7.5% increase in revenue per patient day and a 1.8% growth in patient days [19][20] Business Line Data and Key Metrics Changes - The company added 101 beds to existing facilities in Q2, totaling 191 beds added for 2025, and 479 beds added to date in 2025 [8][10] - Same facility patient days increased by 1.8%, with strong performance in specialty and comprehensive treatment centers (CTCs) [11][12] - The company experienced a slight decline in Medicaid volumes year-over-year in its acute care hospitals, while commercial and Medicare volumes increased by 98% respectively [12] Market Data and Key Metrics Changes - The company anticipates approximately $230 million in gross revenue from existing state Medicaid supplemental programs for the full year 2025, with potential reductions starting in fiscal 2028 [6][20] - The approval of the Tennessee supplemental payment program resulted in a favorable pre-tax benefit of $51.8 million for the quarter [20] Company Strategy and Development Direction - The company remains committed to delivering essential care to underserved populations and prioritizes partnerships with payers and state agencies [7] - The company is focusing on quality initiatives and technology investments to enhance patient safety and care coordination [12][15] - The company plans to pause some capital spending to unlock more free cash flow and reduce startup costs [35][36] Management's Comments on Operating Environment and Future Outlook - Management noted that the primary driver of lower-than-expected volumes was weaker Medicaid volumes in the acute care business, reflecting evolving utilization patterns among managed Medicaid plans [26][27] - The company expects adjusted EBITDA for the full year to be in the range of $675 million to $700 million, with startup losses projected to be approximately $60 million to $65 million [21][22] - Management expressed confidence in the long-term growth potential despite current challenges, emphasizing the importance of quality care and operational efficiency [15][34] Other Important Information - Heather Dixon, the Chief Financial Officer, will be stepping down, and Tim Sides will assume the role of Interim CFO [17][18] - The company is experiencing more favorable labor trends in 2025, supported by initiatives focused on recruitment and retention [16] Q&A Session Summary Question: Can you elaborate on the Medicaid volume issues? - Management indicated that weaker Medicaid volumes were primarily due to evolving utilization patterns among managed Medicaid plans, impacting admissions trends [26][27] Question: What is driving the increase in startup costs? - The increase in startup costs is due to an accelerated opening pace of new facilities, resulting in earlier-than-expected costs [28][29] Question: How does the company view free cash flow opportunities in 2026? - Management believes there is an opportunity to accelerate the path to becoming free cash flow positive by pausing some capital spending [34][35] Question: What is the impact of underperforming facilities on patient volumes? - Underperforming facilities had a negative impact of about 80 basis points on same facility patient volume growth in Q2, with management monitoring the situation closely [42][43] Question: How is the company addressing referral sources for underperforming facilities? - The company is actively engaging with referral sources to highlight the quality of care and investments made in technology and patient outcomes [95][96]